User-producer interactions in emerging pharmaceutical and food innovations

International Journal of Innovation Management

Volumn 12, Issue 3, 2008, Pages 459-487

  Moors, E H M ^a   Boon, W P C ^a   Nahuis, R ^a   Vandeberg, R L J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Demand articulation; Emerging innovations; Interactive learning; User producer interaction

Indexed keywords

EID: 53249115458     PISSN: 13639196     EISSN: None     Source Type: Journal    
DOI: 10.1142/S1363919608001984     Document Type: Article

References (85)

1. Akrich, M (1995). User representations: Practices, methods and sociology. In Managing Technology in Society. The Approach of Constructive Technology Assessment, A Rip, J Misa and J Schot (eds.), pp. 167-184. London and New York: Pinter Publishers.
2. Atun, RA, I Gurol-Urganci and D Sheridan (2007). Uptake and diffusion of pharmaceutical innovations in health systems. International Journal of Innovation Management, 11(2), 299-321.
3. Atun, RA and D Sheridan (2007). Editorial: Innovation in health care: the engine of technological advances. International Journal of Innovation Management, 11(2), 5-10.
4. Autio, E, S Kanninen and R Gustafsson (2008). First- and second-order additionality and learning outcomes in collaborative R&D programs. Research Policy, 37(1), 59-76.
5. Bijker, WE (1995). Of Bicycles, Bakelites, and Bulbs. Toward a Theory of Sociotechnical Change. Cambridge, MA: The MIT Press.
6. Boon, WPC, EHM Moors, S Kuhlmann and REHM Smits (2008). Demand articulation in intermediary organisations: The case of orphan drugs in the Netherlands. Technological Forecasting and Social Change, 75(5), 644-671.
7. Boon, WPC (2007a). Storyline of Herceptin Reimbursement - Case Study Report on the Dutch Breast Cancer Association. Utrecht: Utrecht University.
8. Boon,WPC (2007b). Case Study Report on the Dutch Neuromuscular Disease Association. Utrecht: Utrecht University.
9. Boon, WPC (2008, In Press). Demanding Dynamics - Demand Articulation of Intermediary Organisations in Emerging Pharmaceutical Innovations (dissertation). Utrecht: Utrecht University.
10. Boschma, RA and JG Lambooy (1999). Evolutionary economics and economic geography. Journal of Evolutionary Economics, 9(4), 411-429.
11. Boschma, R (2005). Proximity and innovation: A critical assessment. Regional Studies - Abingdon 00039/00001 (2005-01-01), 61-75.
12. Bucchi, M and F Neresini (2008). Science and public participation. In The Handbook of Science and Technology Studies, EJ Hackett, O Amsterdamska, M Lynch and J Wajcman (eds.), pp. 449-472. Cambridge, Massachusetts: The MIT Press.
13. Clark, KB (1985).The interaction of design hierarchies and market concepts in technological evolution. Research Policy, 14, 235-251.
14. Cohen, WM and DA Levinthal (1990). Absorptive capacity: A new perspective on learning and innovation. Administrative Science Quarterly, 35(1), 128-152.
15. Collingridge, D (1980). The Social Control of Technology. London: Pinter.
16. COM (2007). Together for health: A strategic approach for the EU 2008-2013. Proc. of the White Paper, Presented by the Commission of the European Communities, Brussels, http://ec.europa.eu/health/ ph_overview/strategy/health_strategy_en.htm [23 October 2007].
17. Coombs, R et al. (2001). Technology and the Market. Demand, Users and Innovation. Northampton, MA: Edward Elgar.
18. Cooper, RG (1993). Winning at New Products: Accelerating the Process from Idea to Launch, 2nd Ed., Cambridge, MA: Addison-Wesley.
19. Dasgupta, P and PA David (1994). Toward a new economics of science. Research Policy, 23, 487-521.
20. DNC (Dutch Nutrigenomics Consortium), internal document for website www.nutrigenomicsconsortium.nl.
21. Doloreux, D (2004). Regional networks of small and medium sized enterprises: Evidence from the metropolitan area of Ottawa in Canada. European Planning Studies, 12(2), 173-189.
22. Dosi,G et al. (2006). How much should society fuel the greed of innovators?: On the relations between appropriability, opportunities and rates of innovation. Research Policy, 35(8), 1110-1121.
23. FDA (2005). Innovation or stagnation. Challenge and opportunity on the critical path to new medical products. FDA report.
24. Fischoff, B (1995). Risk perception and communication unplugged: Twenty years of progress. Risk Analysis, 15(2), 137-145.
25. Fleck, J (1994). Learning by trying. The implementation of configurational technology. Research Policy, 23(6), 637-652.
26. Fleck, J (1988). Innofusion or diffusation? The nature of technological developments in robotics. Edinburgh PICT Working Paper.
27. Franke, N and E Von Hippel (2003). Satisfying heterogeneous user needs via innovation toolkits: The case of Apache security software. Research Policy, 32(7), 1199-215.
28. Feldman, MP (1994). The Geography of Innovation. Dordrecht: Kluwer.
29. Frenken, K and FG Van Oort (2004). The geography of research collaboration: Theoretical considerations and stylised facts in biotechnology in Europe and the United States. In Regional Economies as Knowledge Laboratories, P Cooke and A Piccaluga (eds.), pp. 38-57. Cheltenham, UK and Northampton, MA: Edward Elgar.
30. Garrety, K and R Badham (2004). User-centered design and the normative politics of technology. Science, Technology & Human Values, 29(2), 191-212.
31. Geels, FW (2002). Understanding the Dynamics of Technological Transitions. A co-evolutionary and socio-technical analysis. PhD thesis, Twente University Press.
32. Gertler, MS (2003). Tacit knowledge and the economic geography of context, or the unde-finable tacitness of being (there). Journal of Economic Geography, 3, 75-99.
33. Geurts, J (1993). Omkijken naar de toekomst, lange termijn verkenningen in beleidsexercities (Looking Back to the Future, Longterm Foresight Studies in Policy Exercises). Tilburg: Samson H.D. Tjeenk Willink.
34. Griffin, A and JR Hauser (1993). The voice of the customer. Marketing Science, 12(1), 1-27.
35. Griffin, A (1996). Obtaining customer needs for product development. In The PDMA Handbook of New Product Development, MD Rosenau, Jr. (ed.), pp. 153-166. New York: John Wiley & Sons Inc.
36. Hamel, G and CK Prahalad (1994). Competing for the Future. Boston, MA: Harvard Business School Press.
37. Hoogma, R and JW Schot (2001). How innovative are users? A critique of learning-by doing and -using. In Technology and the Market. Demands, Users and Innovation, R Coombs, K Green, A Richards and V Walsh (eds.), pp. 216-233. Cheltanhem, UK, Edward Elgar.
38. Howells, JRL (2002). Tacit knowledge, innovation and economic geography. Urban Studies, 39(5), 871-884.
39. Kaput, J, JM Ordovas, L Ferguson, B van Ommen, RL Rodriguez and L Allen (2005). Horizons in nutritional science. The case for strategic alliances to harness nutritional genomics for public and personal health. British Journal of Nutrition, 94, 623-632.
40. Kaput, J, A Perlina, B Hatipoglu, A Bartholomew and Y Nikolsky (2007). Nutrigenomics: Concepts and applications to pharmacogenomics and clinical medicine. Pharmacogenomics, 8(4), 369-390.
41. Lettl, C, C Herstatt and HG Gemuenden (2006). Users' contribution to radical innovation: Evidence from four cases in the field of medical equipment technology. R&D Management, 36(3), 251-272.
42. Lundvall,BA(1988). Innovation as an interactive process: Fromuser-producer interaction to the national system of innovation. In Technical Change and Economic Theory, Dosi, G, C Freeman, R Nelson, G Silverberg and L Soete (eds.), pp. 349-369. London: Pinter Publishers.
43. Lundvall, BA (1992). National Systems of Innovation: Towards a Theory of Innovation and Interactive Learning. London: Pinter Publishers.
44. Lütje, C (2003). Customers as co-inventors: An empirical analysis of the antecedents of customer-driven innovations in the field of medical equipment. Proc. of the 32nd Annual Conference of the European Marketing Academy (EMAC), Glasgow.
45. Malmberg A and P Maskell (1999). Guest editorial: Localized learning and regional economic development. European Urban and Regional Studies 6(1), 5-8.
46. Martin, P (2001). Great expectations: The construction of markets, products and user needs during the early development of gene therapy in the USA. In Technology and the Market. Demand, Users and Innovation R Coombs, K Green, A Richards and V Walsh (eds.), pp. 38-67. Northampton, MA: Edward Elgar.
47. Menrad, K (2003). Market and marketing of functional food in Europe. Journal of Food Engineering, 56, 181-188.
48. Moors, EHM, C Enzing, A Van der Giessen and REHM Smits (2003). User-producer interactions in functional genomics innovations. Innovation: Management, Policy & Practice, 5(2-3), 120-143.
49. Moors, EHM and H Schellekens (2008). Medical biotechnology and sustainable drug development. In General Aspects in Biopharmaceuticals for European Hospital Pharmacists, H Schellekens and AG Vulto (eds.), Chap. 1, Mol(B): Pharma Publishing & Media Europe 2008, 7.
50. Nahuis, R and H Van Lente (2008).Where are the politics? Perspectives on democracy and technology. Science, Technology & Human Values 33(5).
51. Nahuis, R, EHM Moors and REHM Smits (2008). User producer interaction in context. A typology.Working Paper. Innovation Studies Group, Utrecht: Utrecht University.
52. Nelson, RR and SG Winter (1982). An Evolutionary Theory of Economic Change. Cambridge/London: The Belknap Press of Harvard University Press.
53. Oudshoorn, N and T Pinch (2003). How Users Matter. The Co-construction of Users and Technology. Cambridge, MA: MIT Press.
54. Poole, MS, AH Van de Ven, K Dooley and ME Holmes (2000). Organizational Change and Innovation Processes. Oxford: Oxford University Press.
55. Renn, O (1998). Three decades of risk research: Accomplishments and new challenges. Journal of Risk Research, 1(1), 49-72.
56. Rip, A and R Kemp (1998). Technological change. In Human Choice and Climate Change, S Rayner and EL Malone (eds.), Vol. 2, Chap. 6, pp. 327-399. Ohio: Battelle Press.
57. Rip, A and JW Schot (2002). Identifying loci for influencing the dynamics of technological development. In Shaping Technology, Guiding Policy. KH Sørensen and R Williams, (eds.), pp. 155-172. Cheltenham, UK: Edward Elgar.
58. Rohracher, H (2005). User Involvement in InnovationProcesses. Strategies and Limitations from a Socio-Technical Perspective. Munchen: Profil Verlag.
59. Rosenberg, N (1982). Inside the Black Box. Technology and Economics Cambridge, MA: Cambridge University Press.
60. Royal Society (2005). Personalised Medicine: Hopes and Realities. London: The Royal Society.
61. Sabatier, PA (1987). Knowledge, policy-oriented learning and policy change: An advocacy coalitions framework. Knowledge, 8, 17-50.
62. Schmidt, JB and RJ Calantone (2002). Escalation of commitment during newproduct development. Journal of the Academy of Marketing Science 30, 103-118.
63. Silverstone, R and E Hirsch (1992). Consuming Technologies. Media and Information in Domestic Spaces. London and New York: Routledge.
64. Smits, REHM (2002). Innovation studies in the 21th century: Questions from a user's perspective. Technological Forecasting and Social Change, 69, 861-883.
65. Smits, R and P Den Hertog (2007). Technology assessment and the management of technology in economy and society. International Journal of Foresight and Innovation Policy, 3(1), 28-52.
66. Smits, REHM and WPC Boon (2008). The role of users in innovation in the pharmaceutical industry. Drug Discovery Today, 13(7/8), 353-359.
67. Star, SL and JR Griesemer (1989). Institutional ecology, 'translations' and boundary objects: Amateurs and professionals in Berkeley's Museum of vertebrate zoology, 1907-39. Social Studies of Science, 19, 387-420.
68. Stewart, J and R Williams (2005). The wrong trousers? Beyond the design fallacy: Social learning and the user. In Handbook of Critical Information Systems Research: Theory and Application, D Howcroft and E Trauth (eds.), pp. 195-221. Cheltenham: Edward Elgar.
69. Stirling, A (1998). Risk at a turning point? Journal of Risk Research 1(2), 97-110.
70. Teubal, M (1979). On user needs and need determination: Aspects of the theory of technological innovation. In Industrial Innovation. Technology, Policy and Diffusion, MJ Maker (ed.), pp. 266-289. London: Macmillan Press.
71. Triggle, D (2007). Treating desires not diseases: A pill for every ill and an ill for every pill? Drug Discovery Today, 12(3/4), 161-166.
72. Trusheim, MR, ER Berndt and FL Douglas (2007). Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nature Reviews Drug Discovery, 6, 287-293.
73. Urala, N and L Lähteenmäki (2007). Consumers' changing attitudes towards functional food. Food Quality and Preference, 18, 1-12.
74. Utterback, JM (1994). Mastering the Dynamics of Innovation. Boston, Massachussets: Harvard Business School Press.
75. Vandeberg, RLJ and EHM Moors (2007).A framework for interactive learning in emerging technologies. Working Paper. Innovation Studies Group. Utrecht: Utrecht University.
76. Vandeberg, RLJ and WPC Boon (2008). Anticipating emerging technologies. Genomics, Society, Policy Journal. (Forthcoming).
77. Vandeberg, RLJ (2008a). Interactive Learning in Emerging Technologies: The Case of the Dutch Nutrigenomics Consortium 2007. Utrecht: Utrecht University - Department of Innovation Studies.
78. Vandeberg, RLJ (2008b). Interactive Learning in Emerging Technologies: The Case of the German Competence Network Metabolic Syndrome. 2007. Utrecht: Utrecht University - Department of Innovation Studies.
79. Vandeberg, RLJ (forthcoming). A framework for interactive learning in emerging technologies - Comparative case studies in national nutrigenomics consortia. Utrecht: Utrecht University (dissertation).
80. Van der Valk, T (2007). Technology Dynamics, Network Dynamics and Partnering - The Case Of Dutch Dedicated Life Sciences Firms. Utrecht: Utrecht University.
81. Van Kleef, E, HCM Van Trijp and P Luning (2005). Consumer research in the early stages of new product development: A critical review of methods and techniques. Food Quality and Preference, 16(3), 181-201.
82. Van Lente, H, MP Hekkert, REHM Smits and B Van Waveren (2003). Roles of systemic intermediaries in transition processes. International Journal of Innovation Management, 7(3), 1-33.
83. Verbeke, W (2005). Consumer acceptance of functional foods: sociodemographic, cognitive and attitudinal determinants. Food Quality and Preference, 16, 45-57.
84. Von Hippel, E (1988). The Sources of Innovation. New York: Oxford University Press.
85. Weterings, ABR (2006). Do Firms Benefit From Spatial Proximity? Utrecht: Utrecht University.